» Articles » PMID: 23722544

Extracellular DNA in Pancreatic Cancer Promotes Cell Invasion and Metastasis

Overview
Journal Cancer Res
Specialty Oncology
Date 2013 Jun 1
PMID 23722544
Citations 50
Authors
Affiliations
Soon will be listed here.
Abstract

Aggressive metastasis is the chief cause of the high morbidity and mortality associated with pancreatic cancer, yet the basis for its aggressive behavior remains elusive. Extracellular DNA (exDNA) is a recently discovered component of inflammatory tissue states. Here, we report that exDNA is present on the surface of pancreatic cancer cells where it is critical for driving metastatic behavior. exDNA was abundant on the surface and vicinity of cultured pancreatic cancer cells but absent from normal pancreas cells. Strikingly, treatment of cancer cell cultures with DNase I to degrade DNA nonspecifically reduced metastatic characters associated with matrix attachment, migration, and invasion. We further assessed the role of exDNA in pancreatic cancer metastasis in vivo using an orthotopic xenograft model established by implantation of pancreatic cancer cells expressing firefly luciferase. Noninvasive bioluminescent imaging confirmed that DNase I treatment was sufficient to suppress tumor metastasis. Mechanistic investigations suggested the existence of a positive feedback loop in which exDNA promotes expression of the inflammatory chemokine CXCL8, which leads to higher production of exDNA by pancreatic cancer cells, with a significant reduction in CXCL8 levels achieved by DNase I treatment. Taken together, our results strongly suggest that exDNA contributes to the highly invasive and metastatic character of pancreatic cancer.

Citing Articles

Cathepsin B Nuclear Flux in a DNA-Guided "Antinuclear Missile" Cancer Therapy.

Cao F, Tang C, Chen X, Tu Z, Jin Y, Turk O ACS Cent Sci. 2024; 10(8):1562-1572.

PMID: 39220699 PMC: 11363321. DOI: 10.1021/acscentsci.4c00559.


Targeting ROS in cancer: rationale and strategies.

Glorieux C, Liu S, Trachootham D, Huang P Nat Rev Drug Discov. 2024; 23(8):583-606.

PMID: 38982305 DOI: 10.1038/s41573-024-00979-4.


Regulated cell death in neutrophils: From apoptosis to NETosis and pyroptosis.

Dejas L, Santoni K, Meunier E, Lamkanfi M Semin Immunol. 2023; 70:101849.

PMID: 37939552 PMC: 10753288. DOI: 10.1016/j.smim.2023.101849.


Mechanisms of Neutrophil Extracellular Trap Formation and Regulation in Cancers.

Zhang Z, Niu R, Zhao L, Wang Y, Liu G Int J Mol Sci. 2023; 24(12).

PMID: 37373412 PMC: 10299318. DOI: 10.3390/ijms241210265.


Inhibitors of Polyphosphate and Neutrophil Extracellular Traps.

Vappala S, Smith S, Kizhakkedathu J, Morrissey J Semin Thromb Hemost. 2023; 50(7):970-977.

PMID: 37192652 PMC: 10651799. DOI: 10.1055/s-0043-1768936.


References
1.
Hanahan D, Weinberg R . Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. DOI: 10.1016/j.cell.2011.02.013. View

2.
Uomo I, Miraglia S, Pastorello M . Inflammation and pancreatic ductal adenocarcinoma: a potential scenario for novel drug targets. JOP. 2010; 11(3):199-202. View

3.
Raimondi S, Maisonneuve P, Lowenfels A . Epidemiology of pancreatic cancer: an overview. Nat Rev Gastroenterol Hepatol. 2009; 6(12):699-708. DOI: 10.1038/nrgastro.2009.177. View

4.
Wen F, Zhou R, Shen A, Choi A, Uribe D, Shi J . The tumor suppressive role of eIF3f and its function in translation inhibition and rRNA degradation. PLoS One. 2012; 7(3):e34194. PMC: 3311619. DOI: 10.1371/journal.pone.0034194. View

5.
Swarup V, Rajeswari M . Circulating (cell-free) nucleic acids--a promising, non-invasive tool for early detection of several human diseases. FEBS Lett. 2007; 581(5):795-9. DOI: 10.1016/j.febslet.2007.01.051. View